Keyphrases
Cervical Carcinoma
100%
Tumor Suppressor Gene
100%
RASSF1A
100%
Promoter Methylation
55%
HPV16
55%
Tumor
33%
Promoter Region
33%
Squamous Cell Carcinoma (SqCC)
33%
Adenocarcinoma
33%
RASSF1A Methylation
33%
Human Cancer
22%
High-risk Human Papillomavirus (HR-HPV)
22%
Hypermethylation
22%
Epigenetic Silencing
22%
Oncogenic Human Papillomavirus
22%
High Incidence
11%
In(III)
11%
Inverse Correlation
11%
Breast Cancer
11%
Lung Cancer
11%
Methylation Status
11%
Methylation
11%
Ovarian Cancer
11%
Genetic Modification
11%
Tumor Protein p53 (TP53)
11%
Human-to-human
11%
Malignant Phenotype
11%
Genetic Changes
11%
Retinoblastoma
11%
Allelic Loss
11%
Papillomavirus Infections
11%
Cervical Cancer
11%
Bisulfite
11%
Carcinoma in Situ
11%
Squamous Carcinoma
11%
PCR Method
11%
Chromosome 3
11%
Short-arm
11%
Loss of Heterozygosity
11%
E6 Protein
11%
E7 Protein
11%
Quantitative Methylation-specific PCR (Q-MSP)
11%
Purpose Development
11%
Uterine Cervical Cancer
11%
Human Papillomavirus Types
11%
3p21.3
11%
PCR System
11%
Medicine and Dentistry
Adenocarcinoma
100%
Uterine Cervix
100%
Tumor Suppressor Gene
100%
Promoter Region
90%
Methylation
60%
Human Papillomavirus Type 16
50%
Infection
40%
Neoplasm
30%
Squamous Cell Carcinoma
30%
Malignant Neoplasm
20%
Polymerase Chain Reaction
20%
Gene Mutation
20%
Wart Virus
20%
Cervical Cancer
20%
Epileptic Absence
10%
Arm
10%
Breast Cancer
10%
Uterine Cervix Carcinoma
10%
Ovarian Cancer
10%
Carcinoma
10%
Lung Cancer
10%
Protein P53
10%
Retinoblastoma
10%
Papillomavirus Infection
10%
Heterozygosity
10%
Chromosome 3
10%
Bisulfite
10%
Protein E7
10%
Protein E6
10%
Immunology and Microbiology
Promoter Region
100%
Uterine Cervix
100%
Tumor Suppressor Gene
100%
Methylation
66%
Human Papillomavirus Type 16
55%
Squamous Cell
33%
Wart Virus
33%
Polymerase Chain Reaction
22%
Epigenetics
22%
Gene Mutation
22%
P53
11%
Arm
11%
Chromosome 3
11%
Heterozygosity
11%
Pharmacology, Toxicology and Pharmaceutical Science
Tumor Suppressor Protein
100%
Adenocarcinoma
100%
Human Papillomavirus Type 16
50%
Infection
40%
Squamous Cell Carcinoma
40%
Neoplasm
30%
Malignant Neoplasm
20%
Human Papillomavirus
20%
Uterine Cervix Cancer
20%
Epileptic Absence
10%
Breast Cancer
10%
Lung Cancer
10%
Ovary Cancer
10%
Protein P53
10%
Papillomavirus Infection
10%
Uterine Cervix Carcinoma
10%
Retinoblastoma
10%
Bisulfite
10%
Protein E6
10%
Protein E7
10%
Biochemistry, Genetics and Molecular Biology
Promoter Region
100%
Tumor Suppressor Gene
100%
Methylation
66%
Human Papillomavirus Type 16
55%
Wart Virus
33%
Epigenetics
22%
Polymerase Chain Reaction
22%
Gene Mutation
22%
Protein P53
11%
Bisulfite
11%
Chromosome 3
11%
Retinoblastoma
11%
Loss of Heterozygosity
11%